Concepedia

Publication | Open Access

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells

32

Citations

28

References

2014

Year

References

YearCitations

Page 1